| Autor: |
Lehmann, David S., Ribaudo, Heather J., Daar, Eric S., Gulick, Roy M., Haubrich, Richard H., Robbins, Gregory K., Bakker, Paul I.W. de, Haas, David W., McLaren, Paul J. |
| Zdroj: |
Pharmacogenetics and Genomics; February 2015, Vol. 25 Issue: 2 p51-59, 9p |
| Abstrakt: |
Efavirenz and abacavir are components of recommended first-line regimens for HIV-1 infection. We used genome-wide genotyping and clinical data to explore genetic associations with virologic failure among patients randomized to efavirenz-containing or abacavir-containing regimens in AIDS Clinical Trials Group (ACTG) protocols. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
